CIP
BHVN icon

Chartwell Investment Partners’s Biohaven BHVN Stock Holding History

Chartwell Investment Partners’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$549K Sell
10,992
-3,298
-23% -$128K 0.02% 394
2024
Q2 		$496K Sell
14,290
-2,340
-14% -$92.5K 0.02% 396
2024
Q1 		$909K Buy
16,630
+4,850
+41% +$240K 0.03% 371
2023
Q4 		$504K Sell
11,780
-12,780
-52% -$397K 0.02% 402
2023
Q3 		$639K Hold
24,560
– – 0.02% 380
2023
Q2 		$587K Buy
24,560
+1,187
+5% +$20.4K 0.02% 384
2023
Q1 		$320K Buy
23,373
+781
+3% +$12.4K 0.01% 399
2022
Q4 		$313K Buy
+22,592
New +$319K 0.01% 395

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Chartwell Investment Partners's BHVN Position: Q3 2024 in Review

Chartwell Investment Partners reduced its Biohaven (BHVN) stake by 23% in Q3 2024, selling an estimated $128K and leaving 10,992 shares worth $549K. The position accounts for 0.02% of the portfolio, ranked #394.

Chartwell Investment Partners first reported a position in BHVN in Q4 2022 and has held it in 8 quarters since. The position peaked at $909K in Q1 2024. 254 funds tracked by Wall St. Rank hold BHVN as of Q3 2024.

  • Chartwell Investment Partners held 10,992 shares of Biohaven worth $549K as of Q3 2024.
  • Chartwell Investment Partners sold 3,298 Biohaven shares in Q3 2024, an estimated $128K.
  • Biohaven made up 0.02% of Chartwell Investment Partners's portfolio in Q3 2024, its #394 holding.
  • Chartwell Investment Partners first reported a position in Biohaven in Q4 2022 and has held it in 8 quarters since.
  • Chartwell Investment Partners's Biohaven position peaked at $909K in Q1 2024.
  • 254 funds tracked by Wall St. Rank held Biohaven as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.